Ilaris®

BIOLOGICAL2 trials

Sponsors

AO GENERIUM

Conditions

Healthy VolunteersStill's Disease Adult Onset

Phase 1

A Safety, Pharmacokinetics and Pharmacodynamics Study of GNR-086 and Ilaris® in Healthy Volunteers

CompletedNCT06481189

AO GENERIUMHealthy Volunteers

Start: 2022-09-06End: 2023-05-26Updated: 2024-07-01

Phase 3

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

CompletedNCT06497491

AO GENERIUMStill's Disease Adult Onset

Start: 2023-12-12End: 2025-07-10Updated: 2025-08-17